Positive results from Ionis’ HAE program

Ionis Pharmaceuticals, Inc. reports its financial results for the first quarter of 2021 and recent business highlights. CEO Brett P. Monia, Ph.D., says:

“In the first quarter, we delivered positive results from our IONIS-PKK-LRx program, demonstrating its potential to change the standard of care for patients with HAE.”
(Source: Ionis)

2021-05-06T16:17:41+02:00May 6, 2021|HAEi News|